Page last updated: 2024-10-28

haloperidol and Anemia, Iron-Deficiency

haloperidol has been researched along with Anemia, Iron-Deficiency in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pawar, RS1
Jain, AP1
Lodhi, S1
Singhai, AK1

Other Studies

1 other study available for haloperidol and Anemia, Iron-Deficiency

ArticleYear
Erythropoietic activity of Asteracantha longifolia (Nees.) in rats.
    Journal of ethnopharmacology, 2010, May-27, Volume: 129, Issue:2

    Topics: Acanthaceae; Anemia, Iron-Deficiency; Animals; Blood Proteins; Erythrocyte Count; Erythrocytes; Fema

2010